ADR 21.1% 2.3¢ adherium limited

Ann: Rimidi Partnership for Respiratory Clinical Management, page-11

  1. 1,577 Posts.
    lightbulb Created with Sketch. 502
    Well I must that was a very refreshing interview to listen to. I very much liked the way he openly discussed what is going on. Kudos to the reporter for asking a lot of good questions that we all wanted answers to. I got more out of that one interview then I have over the past 2 years.

    OK, Another C/R coming. Will we see this one heavily discounted like the last or will it be only slightly less then what it is trading at currently. I could imagine free attaching options will be part of the offer. But I would have thought a placement would have been easier then going to us already beaten down share holders scarred from the last punishing raise.

    In saying that, I do like this guy running the show. He knows his stuff and looks to be the person to get us back in the black.

    Before I would even consider participating again in a C/R I would have to see a detailed break down of where the funds are getting spent and used for. If to much of it is just to keep the high running costs of this company then no way, not one more red cent from me. I'd like to see the operating costs rained in.

    Will wait and see what the prospectus looks like.
 
watchlist Created with Sketch. Add ADR (ASX) to my watchlist
(20min delay)
Last
2.3¢
Change
0.004(21.1%)
Mkt cap ! $8.971M
Open High Low Value Volume
2.9¢ 3.1¢ 2.2¢ $487.2K 18.72M

Buyers (Bids)

No. Vol. Price($)
3 155000 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 300000 2
View Market Depth
Last trade - 16.10pm 24/05/2024 (20 minute delay) ?
Last
2.2¢
  Change
0.004 ( 22.2 %)
Open High Low Volume
2.9¢ 2.9¢ 2.2¢ 11634195
Last updated 15.59pm 24/05/2024 ?
ADR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.